ROSEN, A TOP RANKED LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action Commenced by the Firm – VERV
TOPTOP Financial (TOP) GlobeNewswire News Room·2024-10-16 05:41

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 15, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”), of the important October 28, 2024 lead plaintiff deadline in the securities class action first filed by the firm. SO WHAT: If you purchased Verve Therapeutics securities during the Class Period you may be entitled to ...